Chris Mathes retweeted
This webinar will enable researchers to expand their knowledge of #ionchannels therapeutics, develop innovative strategies, and accelerate the development of new, more effective treatments for patients burdened by chronic trigeminal pain.
hubs.la/Q031sWbP0
#drugdiscovery
Registration is open for the Cambridge Ion Channel Forum 2025. Join us on 15th May for an exciting agenda featuring speakers from academia & industry.
𝐑𝐞𝐠𝐢𝐬𝐭𝐫𝐚𝐭𝐢𝐨𝐧 𝐢𝐬 𝐧𝐨𝐰 𝐨𝐩𝐞𝐧: hubs.la/Q033Tnld0
#ionchannels #electrophysiology #cicf25 #drugdiscovery
Chris Mathes retweeted
𝐒𝐭𝐫𝐮𝐠𝐠𝐥𝐢𝐧𝐠 𝐰𝐢𝐭𝐡 #𝐝𝐫𝐮𝐠𝐝𝐢𝐬𝐜𝐨𝐯𝐞𝐫𝐲 𝐟𝐨𝐫 𝐧𝐞𝐮𝐫𝐨𝐥𝐨𝐠𝐢𝐜𝐚𝐥 𝐝𝐢𝐬𝐨𝐫𝐝𝐞𝐫𝐬 𝐥𝐢𝐤𝐞 𝐩𝐚𝐢𝐧?
We offer tailored neuronal assays:
✔️ High-quality electrophysiology
✔️ Custom solutions
✔️ Rapid data reporting
hubs.la/Q02ZR_rY0
Chris Mathes retweeted
𝐀𝐫𝐞 𝐲𝐨𝐮 𝐜𝐨𝐧𝐟𝐢𝐝𝐞𝐧𝐭 𝐢𝐧 𝐲𝐨𝐮𝐫 𝐜𝐚𝐫𝐝𝐢𝐚𝐜 𝐬𝐚𝐟𝐞𝐭𝐲 𝐚𝐬𝐬𝐞𝐬𝐬𝐦𝐞𝐧𝐭𝐬?
Empower researchers with reliable, high-quality data to:
✔️ Identify risks early
✔️ Optimise resources
✔️ Drive safer drug discovery
hubs.la/Q030Yklv0
Chris Mathes retweeted
Metrion's pioneering ion channel research has contributed to recognition in 𝐓𝐡𝐞 𝐒𝐮𝐧𝐝𝐚𝐲 𝐓𝐢𝐦𝐞𝐬 100 𝐓𝐞𝐜𝐡, celebrating Britain’s fastest-growing private tech companies. Read more: hubs.ly/Q03364V50
#sundaytimes100 #drugdiscovery #ionchannels #preclinical
I am super excited to have a front row seat as moderator for this pain webinar next month! @Goldpainlab and I were grad students together in the Neuroscience program at UCLA a few years back. I always enjoy hearing the latest from his great research team. #Pain
This webinar will enable researchers to expand their knowledge of #ionchannels therapeutics, develop innovative strategies, and accelerate the development of new, more effective treatments for patients burdened by chronic trigeminal pain.
hubs.la/Q031sxWy0
#drugdiscovery
Glad to be at the @AmEpilepsySoc conference in LA to tell the @Metrion_Biosci @KCNC1foundation and @PerlaraPBC story about searching for potential treatments for a rare form of #epilepsy - DM for a PDF copy of the poster
#IonChannels #AES24
Chris Mathes retweeted
Our panel of models, with increasing complexity and translational relevance, allow for more accurate prediction of human responses, reduce the risk of late-stage failures and provide a thorough understanding of drug mechanisms.
hubs.la/Q02PRFlQ0
#neuroscience #cns
Chris Mathes retweeted
Steve Jenkinson will be attending the American College of Toxicology Annual Meeting. Meet up with Steve to discuss how to reliably evaluate the proarrhythmic and cardiotoxic liabilities of your compounds. hubs.la/Q02TgfHc0
#cardiacrisk #drugdiscovery #drugsafety
Chris Mathes retweeted
If you missed our poster 'Identification of venom fractions as TREK-1 modulators using Qube 384 automated patch clamp system' at Neuroscience let us know and we will send you a copy.
#drugdiscovery #ionchannels #neuroscience #cns
TRPM7 #IonChannels and potential anti-viral therapeutics. Cool!
nature.com/articles/s41467-0…
I am excited to have a front row seat at this Metrion Biosciences webinar as moderator! Be sure to register even if the time slot is not convenient...you can always watch later on demand (like Netflix!). #IonChannels
Next week we are proud to host a webinar which presents the patient perspective, electrophysiological research, and technologies used to develop a potential treatment for KCNC1-related disorders.
Register: hubs.la/Q02PPYvt0
#drugdiscovery #CNS #raredisease #rarediseases
I'm excited to moderate this webinar. Even if the day/time is not convenient, be sure to register to learn more about this amazing #IonChannels case study and watch later on demand!
18 September • WEBINAR
Recent Progress Towards a Potential Treatment for KCNC1-related Disorders.
Register: hubs.la/Q02Gnclb0
#drugdiscovery #CRO #CNS #screening #lifesciences #ionchannels #drugrepurposing #epilepsy #raredisease #rarediseases
I always had a hunch that phosphatidic acid regulates ion channel function. This paper from @RohacsTibor and colleagues shows this nicely.
nature.com/articles/s41467-0…
#IonChannels
I'm thrilled to be at Metrion as the new CCO and to be back to my roots in #IonChannels and neuroscience
Cambridge, UK, 23 July 2024: Metrion Biosciences Ltd, the specialist preclinical #CRO and a leader in #ionchannel screening, today announced the appointment of Dr Chris Mathes, MBA, as Chief Commercial Officer (CCO).
hubs.la/Q02HBfMK0
#newhire #CCO #drugdiscovery
Interesting open access review article on the role of #IonChannels and transporters in liver cancer. It seems that ion channels are indeed important targets in drug discovery for cancer treatments.
nature.com/articles/s41417-0…
Exciting news from @CalciMedicaInc - congrats Kenneth Stauderman and team! Great news for patients and go #IonChannels!
fiercebiotech.com/biotech/ca…
Hey @UTDPainLab @mikehildebrand7 @KhannaLabUF
Please help us spread the word!
AnaBios announces 4th Annual Translational Research Grant for award of $15,000. The high-quality human tissue samples award will help the winning academic #researcher advance his/her #translationalresearch project. #drugdiscovery #painresearch #toxicology anabios.com/translational-re…
Report: Every dollar of NIH research funding doubles in economic returns fiercebiotech.com/research/r…
This is good to know!
Chris Mathes retweeted
For #TranslationalTuesday, we're sharing our latest webinar about selection criteria & variability sources that impact performance of cryopreserved primary human hepatocytes when used in in vitro cell culture. #drugdiscovery #earlyhumaninsights youtu.be/znipDjhFp1c?si=vXVj…


















